Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Recommended
Recent
Webcasts
Press releases

Latest research

Trending

Upcoming webcasts

Inderes illustration

Connecting investors and companies

Inderes is a hub connecting investors and listed companies. We are home to over 70 000 investors and 400 Nordic listed companies. Log in to keep up with your favourite companies!

Create an accountLog in
 
OMXHPI-0.32 %
OMXH25-0.14 %
OMXSPI+0.03 %
BRETEC+8.85 %
KAMUX+6.76 %
SBI+5.65 %
NOKIA-4.50 %
IQMX-5.50 %
VINCIT-5.60 %
 
Article16.11.2026 klo 07.45
by Marianne Palmu

Tailwinds picked up in AI stocks, while China's growth engine is sputtering again

Last week was a rising week in the European and US markets, albeit a stormy one. The relationship scandal involving Nvidia CEO Jensen Huang and his subsequent departure reminded investors in the sector that there are always risks behind returns.

Analyst Comment16.11.2026 klo 07.30
by Matias Sainio, Joonas Sjöblom, Tino Korjala

Recurring revenue carries the load, Videosync moves into clients’ AI assistants

Today, Friday 13 November 2026, Inderes published its October revenue, which grew 5% to EUR 1,9 (1,8) million.

Inderes
Revenio Q3'26: Bottoming out ahead of synergies
Research13.11.2026 klo 17.59
by Juha Kinnunen

Revenio Q3'26: Bottoming out ahead of synergies

Revenio's earnings in Q3 were clearly below our expectations as the combined company's cost base proved to be heavier than anticipated. Earnings growth in the coming years now rests even more than before on the realization of synergies.

Revenio Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Bioretec Q3'26: US growth finds its footing
Research13.11.2026 klo 10.30
by Antti Siltanen

Bioretec Q3'26: US growth finds its footing

Commercialization is progressing most sharply in the US.

Bioretec
Koskisen Q3'26: Mild defensive victory is not yet enough to sway our view
Research13.11.2026 klo 13.51
by Antti Viljakainen

Koskisen Q3'26: Mild defensive victory is not yet enough to sway our view

Koskisen's Q3 numbers surpassed our lowered expectations from the preview, but, as we anticipated, a rapid turnaround in demand is not in sight.

Koskisen
Reaktor Q3'26: Software Product business unwinds undervaluation
Research12.11.2026 klo 13.57
by Joni Grönqvist

Reaktor Q3'26: Software Product business unwinds undervaluation

Although Reaktor's Q3 revenue fell slightly short of our expectations, operational efficiency pushed adjusted EBIT well above our forecast. We made only marginal changes to our forecasts.

Reaktor Group
Modulight: Quantum order lifts estimates
Research12.11.2026 klo 10.05
by Antti Siltanen

Modulight: Quantum order lifts estimates

We incorporate Modulight's recent order into our forecasts and revise our target price upwards.

Modulight
Mandatum Q3'26: One weak sales quarter doesn't change the whole story
Research11.11.2026 klo 11.01
by Kasper Mellas, Sauli Vilén

Mandatum Q3'26: One weak sales quarter doesn't change the whole story

Mandatum's Q3 result surpassed our estimates, driven by the net finance result, but asset management sales, crucial to the group's value, remained sluggish

Mandatum
Article12.11.2026 klo 07.33
by Marianne Palmu

Labor share is at rock bottom, but the outlook is brightening

The US employment figures presented a mixed picture from the employee's perspective: the employment situation improved further in October, but at the same time, wage growth slowed down, a trend that has been ongoing for several years. What is this due to? From the "market share" eaten away by artificial intelligence in the labor market, where the employee is in a suffering position, or something else?

Multitude Q3'26: Business performs, but valuation lags
Research13.11.2026 klo 07.57
by Roni Peuranheimo

Multitude Q3'26: Business performs, but valuation lags

Multitude’s Q3 earnings exceeded our expectations, driven by lower-than-expected impairment losses.

Multitude
Article11.11.2026 klo 07.34
by Marianne Palmu

Inflation figures sparked hawkish rhetoric from central bankers

The bond markets are turning in a tighter direction in both the United States and the euro area. Inflation is accelerating, which has led central bankers at both the ECB and the Fed to talk about rate hikes.

Article10.11.2026 klo 07.54
by Marianne Palmu

A blue wave brings no economic miracle

The Democrats took control of both the House of Representatives and the Senate in the midterm elections, and the message from voters was clear: the economy must work for the common people.

Solwers Q3'26: Bearing the risk isn't appealing at this point
Research13.11.2026 klo 11.39
by Atte Jortikka

Solwers Q3'26: Bearing the risk isn't appealing at this point

This weak quarter continued the trend of several years of earnings turnaround being postponed time and again, while debt accumulated through acquisitions weighs increasingly heavily.

Solwers
Regulatory press release11.11.2026 klo 18.15

Inside information, profit warning: Oriola revises its outlook for 2026

Oriola
Teleste Q3'26: Moving forward despite uncertainties
Research09.11.2026 klo 11.05
by Atte Riikola

Teleste Q3'26: Moving forward despite uncertainties

Based on our estimates for next year, Teleste's share valuation is very low (2027e EV/EBIT 7.4x) if the earnings growth materializes.

Teleste
Bioretec Q3'26: ActivaScrew Enters the US Market9:01
Video12.11.2026 klo 13.41
by Antti Siltanen

Bioretec Q3'26: ActivaScrew Enters the US Market

Bioretec's growth in Q3 was broad-based, with revenue in the United States more than doubling. Growth was also strong in other geographical regions. In September, the FDA granted marketing authorization for the ActivaScrew screw, which is expected to support growth in the US market.

Bioretec
Article09.11.2026 klo 07.33
by Marianne Palmu

An unbreakable US labor market?

The week was wild on the markets, ultimately ending up lower in the US and higher in Europe. The Democrats' rise to a majority in Congress raised questions about the regulation of artificial intelligence investments, and Nasdaq experienced its biggest daily drop since March 2020. However, the economic picture still looks strong.

Koskisen Q3'26: Revenue growth continued for the 11th consecutive quarter19:31
Video12.11.2026 klo 14.25
by Antti Viljakainen

Koskisen Q3'26: Revenue growth continued for the 11th consecutive quarter

Koskisen released its seasonally quiet Q3 earnings report this morning.

Koskisen
Orthex Q3'26: What cost pressure?
Research06.11.2026 klo 11.47
by Thomas Westerholm

Orthex Q3'26: What cost pressure?

Orthex's Q3 report dispelled concerns about its ability to defend its margin amid severe cost inflation, as higher raw material prices were reflected in the company's figures in full for the first time.

Orthex
Enersense Q3'26: Year-end is the proving ground
Research06.11.2026 klo 10.05
by Aapeli Pursimo

Enersense Q3'26: Year-end is the proving ground

In our view, Enersense’s Q3 report was on the soft side overall, given the operating margin, the order book trend, and cash flow.

Enersense International

Latest research

Equity Brief: Truecaller
Truecaller
13.11.2026
Fasadgruppen Q3'26: Earnings beat supports the investment case
Buy
Fasadgruppen
13.11.2026
Starbreeze Q3'26: Encouraging signals, but the proof is still pending
Reduce
Starbreeze
13.11.2026
Solwers Q3'26: Bearing the risk isn't appealing at this point
Reduce
Solwers
13.11.2026
Koskisen Q3'26: Mild defensive victory is not yet enough to sway our view
Reduce
Koskisen
13.11.2026
View all

Trending

Mandatum Q3'26 flash comment: Uncertainty slowed down asset management sales
10.11.2026 Analyst Comment
Mandatum Q3'26: One weak sales quarter doesn't change the whole story
11.11.2026 Research
Revenio Q3'26: Bottoming out ahead of synergies
13.11.2026 Research
Danish court's decision favorable for Nordea
10.11.2026 Analyst Comment
Tokmanni Q3'26: Valoa ulkomailta
09.11.2026 Research

Upcoming webcasts

F-Secure, IR-tilaisuus
24.11.2026 klo 10.00 F-Secure
Atria Oyj, CMD
25.11.2026 klo 10.00 Atria
Life Science Night | November 30, 2026
30.11.2026 klo 16.00 Aiforia Technologies
Show all